Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complicat
about
Resistance of retinal inflammatory mediators to suppress after reinstitution of good glycemic control: novel mechanism for metabolic memoryCirculating Biomarkers of Diabetic Retinopathy: An Overview Based on PhysiopathologyMolecular Markers of Diabetic Retinopathy: Potential Screening Tool of the Future?Assessment of bone turnover and bone quality in type 2 diabetic bone disease: current concepts and future directionsThe Role of the Reactive Oxygen Species and Oxidative Stress in the Pathomechanism of the Age-Related Ocular Diseases and Other Pathologies of the Anterior and Posterior Eye Segments in AdultsEpigenetic Changes in Endothelial Progenitors as a Possible Cellular Basis for Glycemic Memory in Diabetic Vascular ComplicationsNeuropathology of type 2 diabetes: a short review on insulin-related mechanismsAdvanced Glycation Endproducts and Bone Material Properties in Type 1 Diabetic MiceEarly progression of diabetic nephropathy correlates with methylglyoxal-derived advanced glycation end productsEmerging drugs for diabetic retinopathy.Biomarkers in Diabetic RetinopathyAccumulation of advanced glycation end (AGEs) products in intensive care patients: an observational, prospective study.Advanced glycation end-products are a risk for muscle weakness in Japanese patients with type 1 diabetes.Mechanisms of metabolic memory and renal hypoxia as a therapeutic target in diabetic kidney disease.Effect of prior intensive therapy in type 1 diabetes on 10-year progression of retinopathy in the DCCT/EDIC: comparison of adults and adolescents.Early urinary markers of diabetic kidney disease: a nested case-control study from the Diabetes Control and Complications Trial (DCCT)GWAS identifies an NAT2 acetylator status tag single nucleotide polymorphism to be a major locus for skin fluorescenceSome views on proteomics in diabetes.Ramipril inhibits AGE-RAGE-induced matrix metalloproteinase-2 activation in experimental diabetic nephropathySerum levels of advanced glycation endproducts and other markers of protein damage in early diabetic nephropathy in type 1 diabetesDifferential effects of glyoxalase 1 overexpression on diabetic atherosclerosis and renal dysfunction in streptozotocin-treated, apolipoprotein E-deficient mice.Higher plasma levels of advanced glycation end products are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study.Progression of carotid artery intima-media thickness during 12 years in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study.Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: the joslin 50-year medalist study.Skin advanced glycation end products glucosepane and methylglyoxal hydroimidazolone are independently associated with long-term microvascular complication progression of type 1 diabetes.Comprehensive identification of glycated peptides and their glycation motifs in plasma and erythrocytes of control and diabetic subjectsSkin intrinsic fluorescence is associated with hemoglobin A(1c )and hemoglobin glycation index but not mean blood glucose in children with type 1 diabetes.Advanced glycation urinary protein-bound biomarkers and severity of diabetic nephropathy in man.Clinical and technical factors associated with skin intrinsic fluorescence in subjects with type 1 diabetes from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications StudySkin autofluorescence is increased in patients with carotid artery stenosis and peripheral artery disease.Early- and advanced non-enzymatic glycation in diabetic vascular complications: the search for therapeutics.Esculin improves dyslipidemia, inflammation and renal damage in streptozotocin-induced diabetic rats.Vitamin D status is associated with skin autofluorescence in patients with type 2 diabetes mellitus: a preliminary reportRole of advanced glycation end products in cardiovascular disease.Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes.Plantar fascia thickness is longitudinally associated with retinopathy and renal dysfunction: a prospective study from adolescence to adulthoodHoney--a novel antidiabetic agent.Correlation of advanced glycation endproducts estimated from skin fluorescence in first-degree relatives: the impact of adjustment for skin pigmentationSkin Autofluorescence and Subclinical Atherosclerosis in Mild to Moderate Chronic Kidney Disease: A Case-Control Study.Advanced Glycation End Products Evolution after Pancreas-Kidney Transplantation: Plasmatic and Cutaneous Assessments.
P2860
Q24647760-BFB325DC-3E76-4E3D-AF50-434B1EA1D5ACQ26744760-10614DFD-86CE-4026-BD7C-4ABB6DAC58C5Q26745555-7AC0B6C6-ECCD-4919-8116-CCA35E5ADB86Q26750574-DC02FB4C-7505-4094-9ACE-DC2B46ADA7BEQ26765813-50F447EA-4F4D-4434-8368-8CA26BFF08E4Q26859263-7FEF42D2-ED2D-41F4-A452-163AB34D72CDQ27694676-96DEE22C-7DA3-4660-8723-52170E2842A2Q28551744-272A097B-4A1F-495A-B9CD-97B802E6FD12Q30410401-8ADE55F1-BC9D-4FB5-B1C5-0450C4ED9EABQ33388498-2CDB103F-2E6E-433E-A545-589FDC235215Q33583030-9A03C715-8840-4D79-89A6-ADECC1204F24Q33586749-45139C32-E720-4121-BBD9-5A970B0B9862Q33633568-876CC546-2A49-47F9-A727-1018AE9AD5FDQ33633674-603C14CF-82F0-40C4-8EAC-D6A83835338EQ33803493-563A6780-7742-4249-90D0-032AE6238827Q33829028-CB5CAE23-E118-414B-9341-8303414FED7AQ33839324-54626C41-BE1E-49EF-B282-D4D0A2702410Q33848339-C24283AE-6D5F-424A-9517-4C0145ED4498Q34067504-1200F042-514B-45CA-9F6B-5DD1598F94CBQ34256592-E1D868E8-373C-40F4-B7E6-B414E4410E42Q34399952-E919B7D3-1D97-45C1-A165-BC2CFB1392D3Q34507243-7F8D300A-38AC-4BC1-9948-927309FBD5BAQ34527201-EDF1D731-7E7D-4787-8240-4FC762C91FE2Q34718476-3DDD6E90-C9EF-48D8-8B6D-E9A0122AAB1FQ34762475-490A5243-A193-4B1D-BA47-FD82D67603C0Q35083863-1029D812-ABF3-4CFD-9C55-F37E3EF103FBQ35123432-0C9086DA-EB5D-4E51-9ACA-FC63B88A02E3Q35237455-0FF6EBB1-0847-4667-9D1B-C979E3DBAD7FQ35596137-073DD8B6-E013-4D7D-8CBB-6B4899A0E602Q35783715-112985CE-08F3-4D12-B014-CF656C0F1D98Q35809946-76348D96-0C30-4E7D-AB13-0B9F8223ACFEQ35836490-5C9A43E6-B4DE-4A1C-9739-F96F37F217F1Q35854784-5EE3B403-E92A-49AF-A989-1C99B294B236Q35929112-F8FA17D6-B48E-4097-B300-B7E2B28864B6Q36030387-2C83E1CF-4F24-4D6A-B3A2-034A5811CABDQ36051272-BFFCA06A-6820-4828-9D7B-8C7D7F206888Q36101651-EC56CAE3-BAAD-42D2-A3FC-26A5E6E76512Q36159140-49A063F4-2920-48F3-8ACD-D4CD26EE9980Q36264876-2AAE2095-E380-4295-865F-8C2B6A7BA673Q36530332-225097F0-2649-4485-B595-4CF0D9582643
P2860
Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complicat
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Glycation and carboxymethyllys ...... es interventions and complicat
@en
Glycation and carboxymethyllys ...... es interventions and complicat
@nl
type
label
Glycation and carboxymethyllys ...... es interventions and complicat
@en
Glycation and carboxymethyllys ...... es interventions and complicat
@nl
prefLabel
Glycation and carboxymethyllys ...... es interventions and complicat
@en
Glycation and carboxymethyllys ...... es interventions and complicat
@nl
P2093
P2860
P1433
P1476
Glycation and carboxymethyllys ...... es interventions and complicat
@en
P2093
DCCT Skin Collagen Ancillary Study Group
David R Sell
Patricia Cleary
Saul Genuth
Vincent M Monnier
Wanjie Sun
William Dahms
P2860
P304
P356
10.2337/DIABETES.54.11.3103
P407
P577
2005-11-01T00:00:00Z